University of Michigan: Glioblastoma Nanomedicine Crosses Into Brain in Mice, Eradicates Recurring Brain Cancer
November 11, 2020
November 11, 2020
ANN ARBOR, Michigan, Nov. 11 (TNSRes) -- The University of Michigan issued the following news release on Nov. 10:
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.
The study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier.
The dis . . .
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.
The study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier.
The dis . . .